Skip to main
TEM

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 17%
Sell 8%
Strong Sell 0%

Bulls say

Tempus AI is a promising company due to its reaffirmed outlook, long-term growth targets, recent note offering, unique AI approach, undervaluation, FDA approval for a new product, potential in data licensing and model development, reinvestment plans, and potential growth in rare diseases and digital AI products. With a target of $75, the company's potential for growth and improved cash generation was further highlighted at the recent Analyst Day.

Bears say

Tempus AI is facing intense competition in the healthcare and artificial intelligence sectors, which poses significant risks to its ability to sustain growth. Its dependency on continuous growth in the Tempus dataset also leaves the company vulnerable to potential loss of market share in the genomic testing market or loss of health system customers. Furthermore, the company's expansion plans in MRD and rare disease bring high expectations, but the volatility of ordering patterns and funding from the U.S. Department of Veterans Affairs could hinder their success.

TEM has been analyzed by 12 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 17% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 12 analysts, TEM has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $69.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $69.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.